CVR Partners, LP logo
CVR Partners, LP UAN
$ 109.54 0.87%

Quarterly report 2025-Q2
added 07-31-2025

report update icon

CVR Partners, LP Financial Statements 2011-2026 | UAN

Annual Financial Statements CVR Partners, LP

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

856 M 737 M 1.07 B 851 M 167 M 3.13 B 4.09 B 3.96 B 6.72 B 3.98 B 8.56 B 13 B 20.2 B 20.9 B

Shares

10.6 M 10.6 M 10.6 M 10.7 M 11.2 M 113 M 113 M 113 M 103 M 73.1 M 73.1 M 73.2 M 73.2 M 73.1 M

Historical Prices

81 69.7 101 79.7 15 28.3 28.5 27.5 50.2 60.9 65.9 103 146 132

Net Income

60.9 M 172 M 287 M 78.2 M -98.2 M -35 M -50 M -72.8 M -26.9 M 62 M 76.1 M 119 M 112 M 132 M

Revenue

525 M 681 M 836 M 533 M 350 M 404 M 351 M 331 M 356 M 289 M 299 M 324 M 302 M 303 M

Cost of Revenue

406 M 449 M 483 M 371 M 325 M 348 M 319 M 315 M 302 M 200 M 198 M - - -

Gross Profit

- - - - - 136 M 103 M 89.6 M 114 M 118 M 128 M 172 M 161 M 174 M

Operating Income

90.4 M 201 M 320 M 134 M -34.9 M 27.4 M 6.31 M -10.3 M 24.6 M 68.7 M 82.8 M 125 M 116 M 136 M

Interest Expense

453 K -33 K 1.11 M 4.71 M 159 K 269 K 6.2 M 62.9 M 48.6 M 6.88 M 6.78 M 6.29 M 3.76 M 205 K

EBITDA

178 M 281 M 402 M 208 M 41.2 M 107 M 77.9 M 63.7 M 80.1 M 97.2 M 110 M 150 M 136 M 155 M

Operating Expenses

- - - - - 25.8 M 25 M 25.6 M 29.3 M 20.8 M 17.7 M 21.1 M 24.1 M 41 M

General and Administrative Expenses

28.4 M 29.5 M 32.2 M 26.6 M 18.2 M 25.8 M 25 M 25.6 M 29.3 M 20.8 M 17.7 M 21.1 M 24.1 M 22.2 M

All numbers in USD currency

Quarterly Income Statement CVR Partners, LP

2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

10.6 M 10.6 M 10.6 M 10.6 M 10.6 M 10.6 M 10.6 M 10.6 M - 10.6 M 10.6 M 10.7 M - 10.7 M 10.7 M 10.7 M - 11.1 M 11.3 M 11.3 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 113 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73.1 M 73 M 73 M 73 M 73 M 73 M 73 M 73 M -

Net Income

38.8 M 27.1 M 3.81 M 26.2 M 12.6 M 731 K 59.9 M 102 M - -19.8 M 118 M 93.7 M - 35 M 7.02 M -25.4 M - -19 M -41.6 M -20.7 M -24.9 M -23 M 19 M -6.08 M -1.37 M -13.1 M -16.5 M -19.1 M -27.4 M -31.6 M -3.44 M -10.3 M -14.5 M -13.4 M -17 M 18 M 18.7 M -13.5 M 27 M 29.8 M 24.8 M 12.7 M 17.1 M 21.5 M 27.9 M 19.7 M 35.4 M 35.6 M 15.3 M 31.6 M 35.1 M 30.2 M 41.2 M 36.3 M 38.2 M 16.7 M

Revenue

169 M 143 M 125 M 133 M 128 M 131 M 183 M 226 M - 156 M 244 M 223 M - 145 M 138 M 60.9 M - 79.5 M 105 M 75.1 M 86.1 M 88.6 M 138 M 91.9 M 98.1 M 79.9 M 93.2 M 79.9 M 78.2 M 69.4 M 97.9 M 85.3 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

114 M 100 M 107 M 93 M 100 M 114 M 109 M 109 M - 160 M 111 M 110 M - 91.8 M 101 M 69 M - 78.3 M 85.3 M 74.7 M - 87.6 M 96.7 M 75.1 M - 71 M 87 M 77.6 M 82.1 M 79.2 M 79.9 M 73.1 M 76.7 M 68.8 M 108 M 47 M 40 M 55.1 M 47.6 M 57 M - - - - - - - - - - - - - - - -

Operating Income

46.3 M 34.6 M 11 M 33.6 M 20.1 M 8.14 M 66.7 M 109 M - -11.9 M 126 M 104 M - 46.3 M 30.3 M -14 M - -3.11 M -25.8 M -4.97 M -9.09 M -7.52 M 34.5 M 9.44 M 8 M 2.53 M -790 K -3.42 M -10.8 M -17 M 12.2 M 5.35 M 962 K 2.38 M 3.7 M 19.7 M 20.4 M -11.8 M 28.7 M 31.5 M 26.5 M 14.4 M 18.8 M 23.1 M 29.7 M 21.3 M 37.1 M 36.8 M 15.9 M 32.3 M 36 M 31.4 M 42.6 M 37.5 M 39.3 M 16.8 M

Interest Expense

30 K 225 K 52 K 165 K 160 K 125 K 52 K -265 K - 54 K 81 K 28 K - 26 K 40 K 4.56 M - 57 K 38 K 27 K - 174 K 35 K 20 K - 30 K 27 K 15.7 M 15.8 M 15.7 M 15.7 M 15.7 M 15.7 M 15.6 M 15.6 M 1.64 M 1.74 M 1.73 M 1.72 M 1.7 M 1.73 M 1.72 M 1.67 M 1.66 M 1.68 M 1.66 M 1.68 M 1.28 M 18 K 13 K 28 K 6 K 16 K 132 K 86 K -29 K

EBITDA

67.2 M 52.6 M 35.7 M 53.6 M 39.4 M 32.3 M 86.5 M 125 M - 10.2 M 147 M 123 M - 63.7 M 51.4 M 117 K - 14.9 M -2.38 M 10.6 M -9.09 M 10.9 M 59.6 M 26 M 8 M 18.6 M 19.6 M 13 M 8.28 M 2.49 M 32.2 M 20.8 M 18.2 M 18.8 M 21.3 M 26.6 M 27.6 M -4.4 M 35.7 M 38.3 M 33.5 M 21.2 M 25.6 M 29.8 M 36.7 M 27.9 M 43.3 M 42.6 M 20.8 M 37.6 M 41.2 M 36.9 M 47.5 M 42.2 M 44 M 21.4 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - - - - - - 94 M 83.3 M - 85.3 M 85.7 M 80 M - 76.1 M 116 M 53.4 M 45.6 M 61.1 M 52.1 M 61.6 M 47.9 M 52.3 M 58.4 M 57.2 M 54.6 M 47.9 M 51.8 M 44.6 M - 42.7 M - - - - - -

General and Administrative Expenses

8.03 M 7.89 M 7.45 M 6.31 M 7.31 M 7.8 M 7.29 M 7.38 M - 8.1 M 7.01 M 8.74 M - 6.62 M 6.8 M 5.89 M - 4.23 M 4.45 M 5.35 M - 6.33 M 6.46 M 6.85 M - 6.39 M 6.9 M 5.66 M 6.88 M 6.08 M 5.75 M 6.91 M 7.28 M 7.26 M 8.34 M 6.39 M 5.62 M 6.04 M 4.52 M 4.58 M 3.82 M 3.96 M 5.27 M 4.65 M 5.27 M 4.59 M 5.59 M 5.63 M - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements CVR Partners, LP UAN
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting CVR Partners, LP plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Agricultural inputs industry

Issuer Price % 24h Market Cap Country
Nutrien Ltd. Nutrien Ltd.
NTR
$ 59.99 0.32 % $ 34.8 B canadaCanada
Акрон Акрон
AKRN
- - - russiaRussia
Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp.
BIOX
$ 1.26 -6.67 % $ 435 M argentinaArgentina
American Vanguard Corporation American Vanguard Corporation
AVD
$ 3.87 2.38 % $ 109 M usaUSA
ФосАгро ФосАгро
PHOR
- - - russiaRussia
China Green Agriculture China Green Agriculture
CGA
- 0.51 % $ 27.6 M chinaChina
ICL Group Ltd ICL Group Ltd
ICL
$ 5.58 0.18 % $ 7.83 B israelIsrael
CF Industries Holdings CF Industries Holdings
CF
$ 83.15 2.24 % $ 15 B usaUSA
Arcadia Biosciences Arcadia Biosciences
RKDA
$ 2.73 -0.73 % $ 3.38 M usaUSA
FMC Corporation FMC Corporation
FMC
$ 15.18 1.1 % $ 1.9 B usaUSA
The Scotts Miracle-Gro Company The Scotts Miracle-Gro Company
SMG
$ 61.85 1.73 % $ 3.56 B usaUSA
Intrepid Potash Intrepid Potash
IPI
$ 30.31 3.34 % $ 390 M usaUSA
Corteva Corteva
CTVA
$ 68.88 -1.8 % $ 47.8 B usaUSA
Marrone Bio Innovations Marrone Bio Innovations
MBII
- -5.9 % $ 180 M usaUSA
Origin Agritech Limited Origin Agritech Limited
SEED
$ 1.14 -0.74 % $ 6.4 M chinaChina
The Mosaic Company The Mosaic Company
MOS
$ 26.04 -1.68 % $ 8.33 B usaUSA
Yield10 Bioscience Yield10 Bioscience
YTEN
- 15.32 % $ 46.6 M usaUSA